February 13, 2024
A Seattle federal judge has nixed an Indian generic-drug maker's bid for about $3 million in attorney fees after it prevailed in a biotherapy company's $950 million lawsuit accusing it of stealing its COVID-19 vaccine, saying the maker didn't convince him it spent extra money litigating the suit.
December 19, 2023
Indian generic-drug maker Emcure Pharmaceuticals Ltd. is now seeking more than $3.2 million in attorney fees after convincing a Washington federal judge to toss on jurisdictional grounds Seattle-based HDT Bio Corp.'s $950 million lawsuit accusing it of stealing its COVID-19 vaccine.
December 04, 2023
A Washington federal judge has thrown out Seattle-based biotechnology company HDT Bio's nearly billion-dollar lawsuit accusing an Indian pharmaceutical firm of ripping off its mRNA platform to develop a new COVID-19 vaccine, at least for now, a docket entry showed Monday.
October 26, 2023
An Indian pharmaceutical company again urged a Washington federal judge to throw out Seattle-based HDT Bio Corp.'s $950 million suit accusing it of stealing trade secrets, claiming in its Thursday request that the dispute is duplicative of an ongoing arbitration in London.
September 22, 2023
Indian pharmaceutical company Emcure again urged a federal judge to toss a $950 million suit over allegedly stolen trade secrets from a small Washington company, arguing in a court filing Friday that it has no business presence in Washington state or anywhere in the U.S.
August 01, 2022
A Seattle federal judge has ruled that it's too soon to decide whether an Indian generic-drug maker can use its minimal connections to the U.S. to ditch a $950 million suit over allegedly stolen trade secrets from a small American company with a proprietary mRNA platform to develop a new COVID-19 vaccine in India.
May 13, 2022
India-based Emcure said Friday that it shouldn't have to face a suit launched in Washington federal court claiming it stole secrets for a new COVID-19 vaccine, saying Washington state isn't the right place for the claims.
March 21, 2022
A Seattle biopharmaceutical company sued India-based Emcure in Washington federal court on Monday, claiming the generic-drug maker stole its secrets for a new COVID vaccine with a proprietary mRNA platform and should pay more than $950 million in damages.